BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hatori A, Yui J, Xie L, Kumata K, Yamasaki T, Fujinaga M, Wakizaka H, Ogawa M, Nengaki N, Kawamura K, Wang F, Zhang MR. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis. Sci Rep 2015;5:17327. [PMID: 26612465 DOI: 10.1038/srep17327] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Wegrzyniak O, Rosestedt M, Eriksson O. Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2021;22:7348. [PMID: 34298967 DOI: 10.3390/ijms22147348] [Reference Citation Analysis]
2 Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH. Evaluation of hepatic fibrosis: A review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY). 2017;42:2037-2053. [PMID: 28624924 DOI: 10.1007/s00261-017-1211-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
3 Li Y, Chen L, Li L, Sottas C, Petrillo SK, Lazaris A, Metrakos P, Wu H, Ishida Y, Saito T, Golden-Mason L, Rosen HR, Wolff JJ, Silvescu CI, Garza S, Cheung G, Huang T, Fan J, Culty M, Stiles B, Asahina K, Papadopoulos V. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience 2021;24:102457. [PMID: 34013171 DOI: 10.1016/j.isci.2021.102457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kawamura K, Kumata K, Takei M, Furutsuka K, Hashimoto H, Ito T, Shiomi S, Fujishiro T, Watanabe R, Igarashi N, Muto M, Yamasaki T, Yui J, Xie L, Hatori A, Zhang Y, Nemoto K, Fujibayashi Y, Zhang MR. Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [(18)F]FEDAC: Prerequisites for clinical application. Nucl Med Biol 2016;43:445-53. [PMID: 27183465 DOI: 10.1016/j.nucmedbio.2016.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Kupa LVK, Drewes CC, Barioni ED, Neves CL, Sampaio SC, Farsky SHP. Role of Translocator 18 KDa Ligands in the Activation of Leukotriene B4 Activated G-Protein Coupled Receptor and Toll Like Receptor-4 Pathways in Neutrophils. Front Pharmacol 2017;8:766. [PMID: 29163156 DOI: 10.3389/fphar.2017.00766] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Wu CY, Hsieh HH, Chu PA, Hong WH, Chang TY, Hsu CF, Lin ST, Su PH, Peng SL. Comparison of 18F-FDG, 18F-Fluoroacetate, and 18F-FEPPA for Imaging Liver Fibrosis in a Bile Duct-Ligated Rat Model. Mol Imaging 2021;2021:7545284. [PMID: 34934405 DOI: 10.1155/2021/7545284] [Reference Citation Analysis]
7 Shao T, Josephson L, Liang SH. PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease. Mol Imaging 2019;18:1536012119871455. [PMID: 31478458 DOI: 10.1177/1536012119871455] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
8 Largeau B, Dupont AC, Guilloteau D, Santiago-Ribeiro MJ, Arlicot N. TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases? Contrast Media Mol Imaging 2017;2017:6592139. [PMID: 29114179 DOI: 10.1155/2017/6592139] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
9 Manabe O, Kikuchi T, Scholte AJHA, El Mahdiui M, Nishii R, Zhang MR, Suzuki E, Yoshinaga K. Radiopharmaceutical tracers for cardiac imaging. J Nucl Cardiol 2018;25:1204-36. [PMID: 29196910 DOI: 10.1007/s12350-017-1131-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
10 Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T. Fibrosis imaging: Current concepts and future directions. Adv Drug Deliv Rev 2017;121:9-26. [PMID: 29108860 DOI: 10.1016/j.addr.2017.10.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 12.6] [Reference Citation Analysis]
11 Lamb CL, Cholico GN, Pu X, Hagler GD, Cornell KA, Mitchell KA. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice. Toxicol Appl Pharmacol 2016;311:42-51. [PMID: 27693115 DOI: 10.1016/j.taap.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
12 Vass L, Fisk M, Lee S, Wilson FJ, Cheriyan J, Wilkinson I. Advances in PET to assess pulmonary inflammation: A systematic review. European Journal of Radiology 2020;130:109182. [DOI: 10.1016/j.ejrad.2020.109182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kawamura K, Kumata K, Mori W, Fujinaga M, Kurihara Y, Ogawa M, Ohkubo T, Furutsuka K, Hashimoto H, Nengaki N, Zhang MR. Radiosynthesis of 18F-fluoroethylated tracers via a simplified one-pot 18F-fluoroethylation method using [18F]fluoroethyl tosylate. Appl Radiat Isot 2021;169:109571. [PMID: 33412382 DOI: 10.1016/j.apradiso.2020.109571] [Reference Citation Analysis]
14 Luo R, Wang L, Ye F, Wang YR, Fang W, Zhang MR, Wang F. [18F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia. Ann Nucl Med 2021;35:927-36. [PMID: 34081287 DOI: 10.1007/s12149-021-01630-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Qi P, Ma MZ, Kuai JH. Identification of growth differentiation factor 15 as a pro-fibrotic factor in mouse liver fibrosis progression. Int J Exp Pathol 2021;102:148-56. [PMID: 33983642 DOI: 10.1111/iep.12398] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Balogh V, MacAskill MG, Hadoke PWF, Gray GA, Tavares AAS. Positron Emission Tomography Techniques to Measure Active Inflammation, Fibrosis and Angiogenesis: Potential for Non-invasive Imaging of Hypertensive Heart Failure. Front Cardiovasc Med 2021;8:719031. [PMID: 34485416 DOI: 10.3389/fcvm.2021.719031] [Reference Citation Analysis]
17 Zhang X, Guo Q, Shi Y, Xu W, Yu S, Yang Z, Cao L, Liu C, Zhao Z, Xin J. 99m Tc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawn. Nuclear Medicine and Biology 2017;49:44-9. [DOI: 10.1016/j.nucmedbio.2017.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Adhikari A, Singh P, Mahar KS, Adhikari M, Adhikari B, Zhang MR, Tiwari AK. Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging. Mol Pharm 2021;18:1507-29. [PMID: 33645995 DOI: 10.1021/acs.molpharmaceut.1c00002] [Reference Citation Analysis]
19 Fujinaga M, Kumata K, Zhang Y, Hatori A, Yamasaki T, Mori W, Ohkubo T, Xie L, Nengaki N, Zhang MR. Synthesis of two novel [18F]fluorobenzene-containing radiotracers via spirocyclic iodonium ylides and positron emission tomography imaging of translocator protein (18 kDa) in ischemic brain. Org Biomol Chem 2018;16:8325-35. [PMID: 30206613 DOI: 10.1039/c8ob01700j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]